TDLP.OB Insider Trading Activity and SEC Form 4 Filings
TDLP.OB insider trading summary
No open-market insider purchases or sales of Transdel Pharmaceuticals Inc (TDLP.OB) have been reported on SEC Form 4 in the past 12 months.
Latest TDLP.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 29, 2008 | Juliet Singh | CEO, Director and President | Buy | $700 (500 @ $1.40) |
| Sep 26, 2008 | Juliet Singh | CEO, Director and President | Buy | $700 (500 @ $1.40) |
| Sep 25, 2008 | Anthony S Thornley | Director | Buy | $3K (3,000 @ $1.05) |
| Sep 23, 2008 | Anthony S Thornley | Director | Buy | $4K (3,000 @ $1.25) |
| Sep 10, 2008 | Anthony S Thornley | Director | Buy | $710 (500 @ $1.42) |
| Sep 3, 2008 | Anthony S Thornley | Director | Buy | $330 (200 @ $1.65) |
| Sep 2, 2008 | Anthony S Thornley | Director | Buy | $300 (200 @ $1.50) |
| Jun 27, 2008 | Anthony S Thornley | Director | Buy | $7K (4,200 @ $1.74) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.